APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atropine

Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.

Selected research

Industry Growth & Trends

Global Atropine Industry Growth and Trends Forecast to 2032

8 January 2026102 pages

Choose your research edition.

Industry ResearchAtropine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Atropine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Atropine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atropine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Atropine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.

Global Atropine key players include C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Atropine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Atropine market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Atropine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Atropine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Atropine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Atropine Market by Company

C²PHARMA

RESONANCE LABORATORIES

ROLABO OUTSOURCING

Minsheng

CR Double-Crane

HENAN PURUI

Albany Molecular Research

Alchem International

SAURAV CHEMICALS

Katsura Chemical

Hangzhou Vega

Wuhan senwayer century

Atropine Segment by Type

Injection

Drop

Gel

Atropine Segment by Application

Gastrointestinal

Ophthalmology

Other

Atropine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atropine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atropine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atropine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Atropine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Atropine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Drop Table 3. Major Company of Gel Table 4. Global Atropine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Atropine Sales by Type (2021-2026) & (Kg) Table 6. Global Atropine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Atropine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Atropine Sales Market Share in Value by Type (2021-2026) Table 9. Global Atropine Price by Type (2021-2026) & (USD/Kg) Table 10. Global Atropine Sales by Type (2027-2032) & (Kg) Table 11. Global Atropine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Atropine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Atropine Sales Market Share in Value by Type (2027-2032) Table 14. Global Atropine Price by Type (2027-2032) & (USD/Kg) Table 15. North America Atropine Sales by Type (2021-2026) & (Kg) Table 16. North America Atropine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Atropine Sales by Type (2021-2026) & (Kg) Table 18. Europe Atropine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Atropine Sales by Type (2021-2026) & (Kg) Table 20. Asia-Pacific Atropine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Atropine Sales by Type (2021-2026) & (Kg) Table 22. Latin America Atropine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Atropine Sales by Type (2021-2026) & (Kg) Table 24. Middle East and Africa Atropine Sales by Type (2021-2026) & (US$ Million) Table 25. Atropine Industry Trends Table 26. Atropine Industry Drivers Table 27. Atropine Industry Opportunities and Challenges Table 28. Atropine Industry Restraints Table 29. Global Atropine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Atropine Revenue Market Share by Company (2021-2026) Table 31. Global Atropine Sales by Company (2021-2026) & (Kg) Table 32. Global Atropine Sales Share by Company (2021-2026) Table 33. Global Atropine Market Price by Company (2021-2026) & (USD/Kg) Table 34. Global Atropine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Atropine Major Company Production Sites and Headquarters Table 36. Global Atropine Company, Product Type & Application Table 37. Global Atropine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Atropine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Atropine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Atropine Sales by Region (2021-2026) & (Kg) Table 42. Global Atropine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Atropine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Atropine Sales Market Share in Value by Region (2021-2026) Table 45. Global Atropine Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 46. Global Atropine Sales by Region (2027-2032) & (Kg) Table 47. Global Atropine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Atropine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Atropine Sales Market Share in Value by Region (2027-2032) Table 50. Global Atropine Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2027-2032) Table 51. Global Atropine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Atropine Sales by Application (2021-2026) & (Kg) Table 53. Global Atropine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Atropine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Atropine Sales Market Share in Value by Application (2021-2026) Table 56. Global Atropine Price by Application (2021-2026) & (USD/Kg) Table 57. Global Atropine Sales by Application (2027-2032) & (Kg) Table 58. Global Atropine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Atropine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Atropine Sales Market Share in Value by Application (2027-2032) Table 61. Global Atropine Price by Application (2027-2032) & (USD/Kg) Table 62. North America Atropine Sales by Application (2021-2026) & (Kg) Table 63. North America Atropine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Atropine Sales by Application (2021-2026) & (Kg) Table 65. Europe Atropine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Atropine Sales by Application (2021-2026) & (Kg) Table 67. Asia-Pacific Atropine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Atropine Sales by Application (2021-2026) & (Kg) Table 69. Latin America Atropine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Atropine Sales by Application (2021-2026) & (Kg) Table 71. Middle East and Africa Atropine Sales by Application (2021-2026) & (US$ Million) Table 72. C²PHARMA Company Information Table 73. C²PHARMA Business Overview Table 74. C²PHARMA Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 75. C²PHARMA Atropine Product Portfolio Table 76. C²PHARMA Recent Development Table 77. RESONANCE LABORATORIES Company Information Table 78. RESONANCE LABORATORIES Business Overview Table 79. RESONANCE LABORATORIES Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 80. RESONANCE LABORATORIES Atropine Product Portfolio Table 81. RESONANCE LABORATORIES Recent Development Table 82. ROLABO OUTSOURCING Company Information Table 83. ROLABO OUTSOURCING Business Overview Table 84. ROLABO OUTSOURCING Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 85. ROLABO OUTSOURCING Atropine Product Portfolio Table 86. ROLABO OUTSOURCING Recent Development Table 87. Minsheng Company Information Table 88. Minsheng Business Overview Table 89. Minsheng Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 90. Minsheng Atropine Product Portfolio Table 91. Minsheng Recent Development Table 92. CR Double-Crane Company Information Table 93. CR Double-Crane Business Overview Table 94. CR Double-Crane Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 95. CR Double-Crane Atropine Product Portfolio Table 96. CR Double-Crane Recent Development Table 97. HENAN PURUI Company Information Table 98. HENAN PURUI Business Overview Table 99. HENAN PURUI Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 100. HENAN PURUI Atropine Product Portfolio Table 101. HENAN PURUI Recent Development Table 102. Albany Molecular Research Company Information Table 103. Albany Molecular Research Business Overview Table 104. Albany Molecular Research Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 105. Albany Molecular Research Atropine Product Portfolio Table 106. Albany Molecular Research Recent Development Table 107. Alchem International Company Information Table 108. Alchem International Business Overview Table 109. Alchem International Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 110. Alchem International Atropine Product Portfolio Table 111. Alchem International Recent Development Table 112. SAURAV CHEMICALS Company Information Table 113. SAURAV CHEMICALS Business Overview Table 114. SAURAV CHEMICALS Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 115. SAURAV CHEMICALS Atropine Product Portfolio Table 116. SAURAV CHEMICALS Recent Development Table 117. Katsura Chemical Company Information Table 118. Katsura Chemical Business Overview Table 119. Katsura Chemical Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 120. Katsura Chemical Atropine Product Portfolio Table 121. Katsura Chemical Recent Development Table 122. Hangzhou Vega Company Information Table 123. Hangzhou Vega Business Overview Table 124. Hangzhou Vega Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 125. Hangzhou Vega Atropine Product Portfolio Table 126. Hangzhou Vega Recent Development Table 127. Wuhan senwayer century Company Information Table 128. Wuhan senwayer century Business Overview Table 129. Wuhan senwayer century Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 130. Wuhan senwayer century Atropine Product Portfolio Table 131. Wuhan senwayer century Recent Development Table 132. North America Atropine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 133. North America Atropine Sales by Country (2021-2026) & (Kg) Table 134. North America Atropine Sales Market Share by Country (2021-2026) Table 135. North America Atropine Sales Forecast by Country (2027-2032) & (Kg) Table 136. North America Atropine Sales Market Share Forecast by Country (2027-2032) Table 137. North America Atropine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Atropine Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Atropine Market Share by Country (2021-2026) Table 140. North America Atropine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Atropine Market Share Forecast by Country (2027-2032) Table 142. Europe Atropine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 143. Europe Atropine Sales by Country (2021-2026) & (Kg) Table 144. Europe Atropine Sales Market Share by Country (2021-2026) Table 145. Europe Atropine Sales Forecast by Country (2027-2032) & (Kg) Table 146. Europe Atropine Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Atropine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Atropine Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Atropine Market Share by Country (2021-2026) Table 150. Europe Atropine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Atropine Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Atropine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Atropine Sales by Country (2021-2026) & (Kg) Table 154. Asia-Pacific Atropine Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Atropine Sales Forecast by Country (2027-2032) & (Kg) Table 156. Asia-Pacific Atropine Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Atropine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Atropine Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Atropine Market Share by Country (2021-2026) Table 160. Asia-Pacific Atropine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Atropine Market Share Forecast by Country (2027-2032) Table 162. Latin America Atropine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 163. Latin America Atropine Sales by Country (2021-2026) & (Kg) Table 164. Latin America Atropine Sales Market Share by Country (2021-2026) Table 165. Latin America Atropine Sales Forecast by Country (2027-2032) & (Kg) Table 166. Latin America Atropine Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Atropine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Atropine Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Atropine Market Share by Country (2021-2026) Table 170. Latin America Atropine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Atropine Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Atropine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Atropine Sales by Country (2021-2026) & (Kg) Table 174. Middle East and Africa Atropine Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Atropine Sales Forecast by Country (2027-2032) & (Kg) Table 176. Middle East and Africa Atropine Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Atropine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Atropine Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Atropine Market Share by Country (2021-2026) Table 180. Middle East and Africa Atropine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Atropine Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Atropine Distributors List Table 185. Atropine Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Atropine Image Figure 2. Global Atropine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atropine Market Size (2021-2032) & (US$ Million) Figure 4. Global Atropine Sales (2021-2032) & (Kg) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (Kg) Figure 7. Drop Image Figure 8. Global Drop Sales YoY Growth (2021-2032) & (Kg) Figure 9. Gel Image Figure 10. Global Gel Sales YoY Growth (2021-2032) & (Kg) Figure 11. Global Atropine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Atropine Market Share by Type 2025 VS 2032 Figure 13. North America Atropine Sales Market Share in Volume by Type in 2025 Figure 14. North America Atropine Sales Market Share in Value by Type in 2025 Figure 15. Europe Atropine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Atropine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Atropine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Atropine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Atropine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Atropine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Atropine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Atropine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Atropine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Gastrointestinal Image Figure 26. Global Gastrointestinal Sales YoY Growth (2021-2032) & (Kg) Figure 27. Ophthalmology Image Figure 28. Global Ophthalmology Sales YoY Growth (2021-2032) & (Kg) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global Atropine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Atropine Market Share by Application 2025 VS 2032 Figure 33. North America Atropine Sales Market Share in Volume by Application in 2025 Figure 34. North America Atropine Sales Market Share in Value by Application in 2025 Figure 35. Europe Atropine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Atropine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Atropine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Atropine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Atropine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Atropine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Atropine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Atropine Sales Market Share in Value by Application in 2025 Figure 43. North America Atropine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America Atropine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Atropine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Atropine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Atropine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe Atropine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Atropine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Atropine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Atropine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific Atropine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Atropine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Atropine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Atropine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America Atropine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Atropine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Atropine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Atropine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa Atropine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Atropine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Atropine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Atropine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Atropine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Drop
  • Gel
Applications
  • Gastrointestinal
  • Ophthalmology
  • Other
Companies covered
  • C²PHARMA
  • RESONANCE LABORATORIES
  • ROLABO OUTSOURCING
  • Minsheng
  • CR Double-Crane
  • HENAN PURUI
  • Albany Molecular Research
  • Alchem International
  • SAURAV CHEMICALS
  • Katsura Chemical
  • Hangzhou Vega
  • Wuhan senwayer century

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Atropine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Atropine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Atropine Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Drop
  8. 1.3.3 Gel
  9. 1.4 Global Atropine Market Size by Type
  10. 1.4.1 Global Atropine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Atropine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Atropine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Atropine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Atropine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Atropine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Atropine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Atropine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Atropine Industry Trends
  2. 2.2 Atropine Industry Drivers
  3. 2.3 Atropine Industry Opportunities and Challenges
  4. 2.4 Atropine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Atropine Revenue (2021-2026)
  2. 3.2 Global Top Players by Atropine Sales (2021-2026)
  3. 3.3 Global Top Players by Atropine Price (2021-2026)
  4. 3.4 Global Atropine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Atropine Major Company Production Sites & Headquarters
  6. 3.6 Global Atropine Company, Product Type & Application
  7. 3.7 Global Atropine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Atropine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Atropine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Atropine Tier 1, Tier 2, and Tier 3
4 Atropine Regional Status and Outlook
  1. 4.1 Global Atropine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Atropine Historic Market Size by Region
  3. 4.2.1 Global Atropine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Atropine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Atropine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Atropine Forecasted Market Size by Region
  7. 4.3.1 Global Atropine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Atropine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Atropine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Atropine by Application
  1. 5.1 Atropine Market by Application
  2. 5.1.1 Gastrointestinal
  3. 5.1.2 Ophthalmology
  4. 5.1.3 Other
  5. 5.2 Global Atropine Market Size by Application
  6. 5.2.1 Global Atropine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Atropine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Atropine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Atropine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Atropine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Atropine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Atropine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Atropine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 C²PHARMA
  2. 6.1.1 C²PHARMA Company Information
  3. 6.1.2 C²PHARMA Business Overview
  4. 6.1.3 C²PHARMA Atropine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 C²PHARMA Atropine Product Portfolio
  6. 6.1.5 C²PHARMA Recent Developments
  7. 6.2 RESONANCE LABORATORIES
  8. 6.2.1 RESONANCE LABORATORIES Company Information
  9. 6.2.2 RESONANCE LABORATORIES Business Overview
  10. 6.2.3 RESONANCE LABORATORIES Atropine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 RESONANCE LABORATORIES Atropine Product Portfolio
  12. 6.2.5 RESONANCE LABORATORIES Recent Developments
  13. 6.3 ROLABO OUTSOURCING
  14. 6.3.1 ROLABO OUTSOURCING Company Information
  15. 6.3.2 ROLABO OUTSOURCING Business Overview
  16. 6.3.3 ROLABO OUTSOURCING Atropine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 ROLABO OUTSOURCING Atropine Product Portfolio
  18. 6.3.5 ROLABO OUTSOURCING Recent Developments
  19. 6.4 Minsheng
  20. 6.4.1 Minsheng Company Information
  21. 6.4.2 Minsheng Business Overview
  22. 6.4.3 Minsheng Atropine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Minsheng Atropine Product Portfolio
  24. 6.4.5 Minsheng Recent Developments
  25. 6.5 CR Double-Crane
  26. 6.5.1 CR Double-Crane Company Information
  27. 6.5.2 CR Double-Crane Business Overview
  28. 6.5.3 CR Double-Crane Atropine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CR Double-Crane Atropine Product Portfolio
  30. 6.5.5 CR Double-Crane Recent Developments
  31. 6.6 HENAN PURUI
  32. 6.6.1 HENAN PURUI Company Information
  33. 6.6.2 HENAN PURUI Business Overview
  34. 6.6.3 HENAN PURUI Atropine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 HENAN PURUI Atropine Product Portfolio
  36. 6.6.5 HENAN PURUI Recent Developments
  37. 6.7 Albany Molecular Research
  38. 6.7.1 Albany Molecular Research Company Information
  39. 6.7.2 Albany Molecular Research Business Overview
  40. 6.7.3 Albany Molecular Research Atropine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Albany Molecular Research Atropine Product Portfolio
  42. 6.7.5 Albany Molecular Research Recent Developments
  43. 6.8 Alchem International
  44. 6.8.1 Alchem International Company Information
  45. 6.8.2 Alchem International Business Overview
  46. 6.8.3 Alchem International Atropine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Alchem International Atropine Product Portfolio
  48. 6.8.5 Alchem International Recent Developments
  49. 6.9 SAURAV CHEMICALS
  50. 6.9.1 SAURAV CHEMICALS Company Information
  51. 6.9.2 SAURAV CHEMICALS Business Overview
  52. 6.9.3 SAURAV CHEMICALS Atropine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 SAURAV CHEMICALS Atropine Product Portfolio
  54. 6.9.5 SAURAV CHEMICALS Recent Developments
  55. 6.10 Katsura Chemical
  56. 6.10.1 Katsura Chemical Company Information
  57. 6.10.2 Katsura Chemical Business Overview
  58. 6.10.3 Katsura Chemical Atropine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Katsura Chemical Atropine Product Portfolio
  60. 6.10.5 Katsura Chemical Recent Developments
  61. 6.11 Hangzhou Vega
  62. 6.11.1 Hangzhou Vega Company Information
  63. 6.11.2 Hangzhou Vega Business Overview
  64. 6.11.3 Hangzhou Vega Atropine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hangzhou Vega Atropine Product Portfolio
  66. 6.11.5 Hangzhou Vega Recent Developments
  67. 6.12 Wuhan senwayer century
  68. 6.12.1 Wuhan senwayer century Company Information
  69. 6.12.2 Wuhan senwayer century Business Overview
  70. 6.12.3 Wuhan senwayer century Atropine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Wuhan senwayer century Atropine Product Portfolio
  72. 6.12.5 Wuhan senwayer century Recent Developments
7 North America by Country
  1. 7.1 North America Atropine Sales by Country
  2. 7.1.1 North America Atropine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Atropine Sales by Country (2021-2026)
  4. 7.1.3 North America Atropine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Atropine Market Size by Country
  6. 7.2.1 North America Atropine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Atropine Market Size by Country (2021-2026)
  8. 7.2.3 North America Atropine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Atropine Sales by Country
  2. 8.1.1 Europe Atropine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Atropine Sales by Country (2021-2026)
  4. 8.1.3 Europe Atropine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Atropine Market Size by Country
  6. 8.2.1 Europe Atropine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Atropine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Atropine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Atropine Sales by Country
  2. 9.1.1 Asia-Pacific Atropine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Atropine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Atropine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Atropine Market Size by Country
  6. 9.2.1 Asia-Pacific Atropine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Atropine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Atropine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Atropine Sales by Country
  2. 10.1.1 South America Atropine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Atropine Sales by Country (2021-2026)
  4. 10.1.3 South America Atropine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Atropine Market Size by Country
  6. 10.2.1 South America Atropine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Atropine Market Size by Country (2021-2026)
  8. 10.2.3 South America Atropine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Atropine Sales by Country
  2. 11.1.1 Middle East and Africa Atropine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Atropine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Atropine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Atropine Market Size by Country
  6. 11.2.1 Middle East and Africa Atropine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Atropine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Atropine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Atropine Value Chain Analysis
  2. 12.1.1 Atropine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Atropine Production Mode & Process
  7. 12.2 Atropine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Atropine Distributors
  10. 12.2.3 Atropine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst